Rossmore Private Capital’s AstraZeneca AZN Stock Holding History

Rossmore Private Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.08M	Buy	37,843 +4,160	+12%	+$782K	0.57%	41
2026 Q1	$6.52M	Buy	33,683 +487	+1%	+$93.9K	0.57%	41
2025 Q4	$6.1M	Buy	33,196 +896	+3%	+$157K	0.54%	44
2025 Q3	$4.96M	Buy	32,300 +183	+0.6%	+$27.7K	0.53%	44
2025 Q2	$4.49M	Buy	32,117 +927	+3%	+$130K	0.52%	48
2025 Q1	$4.58M	Buy	31,190 +1,277	+4%	+$185K	0.56%	45
2024 Q4	$3.99M	Hold	29,913	–	–	0.49%	50
2024 Q3	$4.66M	Sell	29,913 -252	-0.8%	-$40.7K	0.58%	45
2024 Q2	$4.71M	Buy	30,165 +7,835	+35%	+$1.18M	0.62%	41
2024 Q1	$3.03M	Buy	+22,330	New	+$2.96M	0.4%	55
2018 Q1	–	Sell	-205	Closed	-$14.2K	–	120
2017 Q4	$14.2K	Buy	+205	New	+$13.8K	0.01%	275

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Rossmore Private Capital's AZN Position: Q2 2026 in Review

Rossmore Private Capital increased its AstraZeneca (AZN) stake by 12% in Q2 2026, buying an estimated $782K and bringing the position to 37,843 shares worth $7.08M. The position accounts for 0.57% of the portfolio, ranked #41.

Rossmore Private Capital first reported a position in AZN in Q4 2017 and has held it in 11 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Rossmore Private Capital held 37,843 shares of AstraZeneca worth $7.08M as of Q2 2026.
Rossmore Private Capital bought 4,160 AstraZeneca shares in Q2 2026, an estimated $782K.
AstraZeneca made up 0.57% of Rossmore Private Capital's portfolio in Q2 2026, its #41 holding.
Rossmore Private Capital first reported a position in AstraZeneca in Q4 2017 and has held it in 11 quarters since.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.